naloxone hydrochloride
naloxone hydrochloride is listed in the FDA National Drug Code directory with 22 NDC codes, marketed under brand names including naloxone hydrochloride, NALOXONE HYDROCHLORIDE, Naloxone Hydrochloride. Available dosage forms: injection, solution, spray, injection.
Drug Details
- Generic Name
- naloxone hydrochloride
- Brand Names
- naloxone hydrochloride, NALOXONE HYDROCHLORIDE, Naloxone Hydrochloride, RiVive
- Application Number
- ANDA214785
- Sponsor
- Baxter Healthcare Corporation
- NDC Codes
- 22
- Dosage Forms
- INJECTION, SOLUTION, SPRAY, INJECTION
- Routes
- INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS, NASAL, PARENTERAL
- Active Ingredients
- NALOXONE HYDROCHLORIDE
Indications and Usage
1 INDICATIONS AND USAGE Buprenorphine and naloxone sublingual tablets are indicated for the maintenance treatment of opioid dependence. Buprenorphine and naloxone sublingual tablets should be used as part of a complete treatment plan that includes counseling and psychosocial support. Buprenorphine and naloxone sublingual tablets contain buprenorphine, a partial opioid agonist, and naloxone, an opioid antagonist, and are indicated for the maintenance treatment of opioid dependence. ( 1 ) Buprenorphine and naloxone sublingual tablets should be used as part of a complete treatment plan that includes counseling and psychosocial support. ( 1 )